Platelet activation is a complex mechanism of response to vascular injury and
atherothrombotic disease, leading to thrombus formation. A wide variety of surface receptors …

Antiplatelet drugs serve as a first-line antithrombotic therapy for the management of acute
ischemic events and the prevention of secondary complications in vascular diseases …

There are only few areas of cardiology that have witnessed such dramatic innovations as
that occurring in the treatment and prophylaxis of thrombotic events. Antithrombotic (ie …

Anti-platelets drugs play an important role in the prevention or treatment of cardiovascular
diseases eg coronary artery disease, stroke, etc., which cause high mortality and morbidity …

Platelets play a key role in thrombosis and haemostasis, which can be either beneficial or
deleterious depending on the circumstance. Antiplatelet therapy is the 'cornerstone'in the …

Platelets play a key role in thrombosis and haemostasis, which can be either beneficial or
deleterious depending on the circumstances. Multiple factors, such as genetic …

Pharmacotherapies with agents that inhibit platelet function have proven to be effective in
the treatment of acute coronary syndromes, and in the prevention of complications during …

Recent development of new antiplatelet agents, including inhibitors of thrombin receptor,
thromboxane receptor, phosphodiesterase, glycoprotein VI, GPIIbIIIa and signaling …

Platelets have long been recognized to be of central importance in haemostasis, but their
participation in pathological conditions such as thrombosis, atherosclerosis and …

Introduction Platelets play a key role in arterial thrombosis and antiplatelet therapy is pivotal
in the treatment of cardiovascular disease. Current antiplatelet drugs target different …